Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024
Addiction · 2026
DOI: 10.1111/add.70378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction, 2026. Verfasst von David T Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Scientist Training Program, School of Medicine, Virginia Commonwealth University, Richmond, VA, USA. Hauptthemen laut MEDLINE: Illicit Drugs, Analgesics, Opioid, Substance Abuse Detection. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute on Drug Abuse of the National Institutes of Health, NIDA NIH HHS, National Institute of Justice, Office of Justice Programs, US Department of Justice.
Abstract (Originalsprache)
Background and aims Nitazenes are a novel subclass of synthetic opioids that have been increasingly implicated in the United States (US) overdose crisis. Despite their growing presence in the illicit drug supply, national trends have not been systematically evaluated. This study aimed to describe temporal and geographic patterns in nitazene detections and assess substances co‐involved in nitazene‐positive biospecimens.
Design
Cross‐sectional study using forensic data from two national sources: the US Drug Enforcement Administration's National Forensic Laboratory Information System (NFLIS) and the Center for Forensic Science Research & Education's (CFSRE) NPS Discovery Program. Setting and cases Nitazene detections in all 50 US states and the District of Columbia between 2019 and 2024.
Measurements
We quantified annual nitazene detections overall and by individual nitazene analog, US Census region and state. Temporal trends were modeled using piecewise linear regression with a Poisson distribution and log link, nationally and by region. NPS Discovery data were used to characterize substances co‐involved with nitazene‐positive biospecimens.
Findings
Between 2019 and 2024, 7117 nitazene analog reports were submitted to NFLIS, increasing from 43 in 2019 to 1905 in 2024. Counts rose sharply from 2019 to 2021 [count ratio = 7.32; 95% confidence interval (CI) = 2.22–24.20] but did not increase statistically significantly from 2021 to 2024 (count ratio = 1.08; 95% CI = 1.00–1.17). Early detections were predominated by isotonitazene (97.7% of NFLIS nitazene reports in 2019) but later shifted toward metonitazene and protonitazene (29.5% and 30.1%, respectively, in 2024). NPS Discovery identified 361 nitazene‐positive biospecimens, increasing from 11 in 2019 to 113 in 2024, with counts increasing by approximately 45% per year (count ratio = 1.45; 95% CI = 1.23–1.71). Nearly all nitazene‐positive biospecimens (98.3%) had at least one co‐detected substance, most commonly fentanyl (54.6%).
Conclusions
Nitazene detections increased sharply across the United States between 2019 and 2024, with shifting patterns in the prevalence of individual nitazenes and extensive polysubstance involvement. These findings highlight the need to strengthen drug testing capacity, expand epidemiological surveillance and implement targeted public health interventions to mitigate harms associated with this emerging class of synthetic opioids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Scientist Training Program, School of Medicine, Virginia Commonwealth University, Richmond, VA, USA.
- Department of Epidemiology, Columbia Mailman School of Public Health, New York, NY, USA.
- Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.
- Center for Forensic Science Research and Education, Fredric Rieders Family Foundation, Horsham, PA, USA.
- College of Life Sciences, Thomas Jefferson University, Philadelphia, PA, USA.
ORCID-Profile: David T Zhu
Förderung
- National Institute on Drug Abuse of the National Institutes of Health
- NIDA NIH HHS
- National Institute of Justice, Office of Justice Programs, US Department of Justice
Zitieren
APA
Zhu, D. T., Fitzgerald, N. D., Palamar, J. J., & Krotulski, A. J. (2026). Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024. Addiction. https://doi.org/10.1111/add.70378
Vancouver
Zhu DT, Fitzgerald ND, Palamar JJ, Krotulski AJ. Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024. Addiction. 2026. doi:10.1111/add.70378
BibTeX
@article{Zhu2026,
author = {Zhu, David T and Fitzgerald, Nicole D and Palamar, Joseph J and Krotulski, Alex J},
title = {Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024},
journal = {Addiction},
year = {2026},
doi = {10.1111/add.70378}
}
EUVIMED